Overall BPTH gets a fundamental rating of 0 out of 10. We evaluated BPTH against 524 industry peers in the Biotechnology industry. Both the profitability and financial health of BPTH have multiple concerns. BPTH is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year BPTH has reported negative net income.
In the past year BPTH has reported a negative cash flow from operations.
BPTH had negative earnings in each of the past 5 years.
BPTH had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -354.57%, BPTH is doing worse than 96.26% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-354.57%
ROE	N/A
ROIC	N/A

ROA(3y)-208.48%

ROA(5y)-145.89%

ROE(3y)-1261.55%

ROE(5y)-779.53%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BPTH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for BPTH has been increased compared to 1 year ago.
BPTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -68.03, we must say that BPTH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BPTH (-68.03) is worse than 95.54% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-68.03

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.86 indicates that BPTH may have some problems paying its short term obligations.
With a Current ratio value of 0.86, BPTH is not doing good in the industry: 90.37% of the companies in the same industry are doing better.
BPTH has a Quick Ratio of 0.86. This is a bad value and indicates that BPTH is not financially healthy enough and could expect problems in meeting its short term obligations.
BPTH's Quick ratio of 0.86 is on the low side compared to the rest of the industry. BPTH is outperformed by 89.48% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.86
Quick Ratio	0.86

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.03% over the past year.

EPS 1Y (TTM)66.03%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%89.06%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 15.40% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y91.32%

EPS Next 2Y39.91%

EPS Next 3Y25.14%

EPS Next 5Y15.4%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BPTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.